| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.044 | 0.3 |